ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
Rjbbb
|
50 |
18K |
2 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
50
|
18K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
Rjbbb
|
50 |
18K |
5 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
50
|
18K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Breakthrough Exosome Therapy
|
|
Rjbbb
|
71 |
24K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
71
|
24K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Breakthrough Exosome Therapy
|
|
Rjbbb
|
71 |
24K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
71
|
24K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Breakthrough Exosome Therapy
|
|
Rjbbb
|
71 |
24K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
71
|
24K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Breakthrough Exosome Therapy
|
|
Rjbbb
|
71 |
24K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
71
|
24K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C - March 2024
|
|
Rjbbb
|
25 |
8.8K |
3 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
25
|
8.8K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C - March 2024
|
|
Rjbbb
|
25 |
8.8K |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
25
|
8.8K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
New valuation - $3.25 SP
|
|
Rjbbb
|
20 |
9.7K |
9 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
20
|
9.7K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
0 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
71
|
24K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
0 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
71
|
24K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
2 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
71
|
24K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
71
|
24K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
71
|
24K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
71
|
24K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Quarterly Activities Report and Appendix 4C - March 2024
|
|
Rjbbb
|
25 |
8.8K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
25
|
8.8K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
71
|
24K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
71
|
24K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
9 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
71
|
24K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
71
|
24K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
71
|
24K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Rjbbb
|
71 |
24K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
71
|
24K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Investor Update
|
|
Rjbbb
|
14 |
5.8K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
14
|
5.8K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega sign Global EXO-NET Agreement
|
|
Rjbbb
|
22 |
7.9K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
7.9K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega sign Global EXO-NET Agreement
|
|
Rjbbb
|
22 |
7.9K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
7.9K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ expands exosome IP
|
|
Rjbbb
|
33 |
11K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
33
|
11K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ expands exosome IP
|
|
Rjbbb
|
33 |
11K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
33
|
11K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Exosomes for non-invasive pre-natal testing
|
|
Rjbbb
|
1 |
1.1K |
10 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1
|
1.1K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
91
|
36K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
91
|
36K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
91
|
36K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
91
|
36K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
91
|
36K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
91
|
36K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
91
|
36K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
Rjbbb
|
91 |
36K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
36K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
Rjbbb
|
12 |
5.2K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
12
|
5.2K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
6 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
228
|
117K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C and Quarterly Activities Report - December 2023
|
|
Rjbbb
|
13 |
5.7K |
7 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
13
|
5.7K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
228
|
117K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
228
|
117K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
4 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
228
|
117K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
5 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
228
|
117K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
4 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
228
|
117K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: 2023 AGM Recording
|
|
Rjbbb
|
43 |
17K |
0 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
43
|
17K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: 2023 AGM Recording
|
|
Rjbbb
|
43 |
17K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
43
|
17K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Screening v monitoring
|
|
Rjbbb
|
11 |
3.2K |
3 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
11
|
3.2K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: 2023 AGM CEO Presentation
|
|
Rjbbb
|
5 |
2.0K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
5
|
2.0K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Rjbbb
|
228 |
117K |
5 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
228
|
117K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Bell Potter Healthcare Conference Investor Presentation
|
|
Rjbbb
|
5 |
3.1K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
5
|
3.1K
|
3
|
|